MedicarePartD.guide

A non-government resource built from CMS public data

Long-acting (basal) insulin on every 2026 Utah Part D plan

Pick a drug class, or type the drugs you want to check, and see which of the 10 stand-alone Part D plans in Utah cover each one, on what tier, and with what restrictions.

A class overrides typed names. Separate names with commas; brand or generic both work.

  • Covered
  • Covered, needs prior authorization (PA) or step therapy (ST)
  • Not on the formulary
  • QL 60/30d = quantity limit, 60 units per 30 days
Long-acting (basal) insulin by 2026 Utah Part D plan
DrugHumana Basic Rx Plan$0.00/moS5884-147Wellcare Value Script$9.60/moS4802-162Humana Value Rx Plan$19.40/moS5884-210Wellcare Classic$23.70/moS4802-021SilverScript Choice$27.70/moS5601-062HealthSpring Extra Rx$56.30/moS5617-381AARP Medicare Rx Saver from UHC$56.50/moS5921-375Humana Premier Rx Plan$115.50/moS5884-177HealthSpring Assurance Rx$128.60/moS5617-153AARP Medicare Rx Preferred from UHC$132.60/moS5921-412
Lantusinsulin glargineTier 325%Tier 325%Tier 320%Tier 325%Tier 319%Tier 317%Tier 317%Tier 3$45.00Tier 321%Tier 317%
insulin glargineunbranded LantusNot coveredTier 325%Not coveredTier 325%Not coveredNot coveredTier 317%Not coveredNot coveredTier 317%
Basaglarinsulin glargineNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Semgleeinsulin glargine-yfgnNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Rezvoglarinsulin glargine-aglrNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot covered
Toujeoinsulin glargine, U-300Tier 325%Not coveredTier 320%Not coveredTier 319%Tier 317%Tier 317%Tier 3$45.00Tier 321%Tier 317%
Tresibainsulin degludecNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredNot coveredTier 3$45.00Not coveredNot covered

Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.